Back to search

France· FR:61955498

FLUCORTAC 100 microgrammes/mL, solution buvable

A fludrocortisone product containing acétate de fludrocortisone, registered in France by HAC PHARMA, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC H02AA02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFLUCORTAC 100 microgrammes/mL, soluti…ATCH02AA02REGISTER NO.FR:61955498PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Fludrocortisone is registered in 15 of 19 countries.

Countries holding a registration under ATC H02AA02 (fludrocortisone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Fludrocortisone · ATC H02AA02

15 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fludrocortisone costs, country by country.

Normalised to the WHO defined daily dose (0.1 mg), the median price runs from $0.27 in Switzerland to $2.47 in France — a ×9.3 gap.

  • France: $2.47 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Fludrocortisone · price per daily dose (0.1 mg)

USD · FX 28 Sept 2026

  • FR France$2.47
  • CH Switzerland$0.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE FLUDROCORTISONE
Manufacturer
HAC PHARMA
Country
France (FR)
ATC code
H02AA02
ATC class
Fludrocortisone
Defined daily dose
0.1 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930245347
    1 flacon en verre brun avec fermeture de sécurité enfant de 50 mL + seringue pour administration orale graduée tous les 0,1 mL.
    EUR 138.98

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

481 interactions on record for fludrocortisone.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fludrocortisone · interactions on record

481 records

  • 59 severe
  • 392 moderate
  • 30 minor

Most severe, free to view

  • AmiodaroneC01BD01severe
  • DofetilideC01BD04severe
  • DronedaroneC01BD07severe
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fludrocortisone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fludrocortisone products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Astonin H
  • Bulgaria · Кортинеф
  • Germany · Astonin H, Fludrocortison Accord
  • Denmark · Cortiflix, Florinef
  • Spain · Astonín, Fludrocortisona
  • Finland · Cortiflix, Florinef
  • United Kingdom (Northern Ireland) · Fludrocortisone Acetate, Fludrocortisone Acetate Accord-Uk
  • Greece · Felusil
  • Croatia · Zonta
  • Hungary · Astonin
  • Ireland · Fludrocortisone Acetate Mylan, Fludrocortisone Acetate Renata
  • Iceland · Florinef
  • Lithuania · Cortineff
  • Luxembourg · Astonin H
  • Latvia · Cortineff, Fludrocortisone Acetate Renata
  • Malta · Fludrocortisone Acetate Renata
  • Netherlands · Florinef Acetaat, Fludrace
  • Norway · Cortiflix, Florinef
  • Poland · Cortineff, Cortineff Ophtalm
  • Portugal · Fludrocortisona Renata
  • Romania · Astonin H
  • Sweden · Cortiflix, Florinef
  • Slovenia · Zonta
  • Slovakia · Zonta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8a68d5f9-c829-4929-b5fa-e30523c84f59
GET /v1/drugs/8a68d5f9-c829-4929-b5fa-e30523c84f59?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61955498",
  "date_amm": "2022-01-05",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "ACÉTATE DE FLUDROCORTISONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about fludrocortisone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.